The primary risk is wasting your $149/month medication investment without achieving your intended therapeutic benefit
The new manufacturing capacity both Novo Nordisk and Lilly are building are also expected to benefit these new drugs as they move onto the market
Nonetheless, scientific research suggests that their combined growth hormone secretagogue actions may be particularly effective at achieving the following health outcomes: Increasing growth hormone circulation Though not exactly common, growth hormone deficiency affects enough people (1 in every 10,000 adults) and causes serious enough problems (depression, insulin resistance, increased body fat) that it behooves us to have a reliable treatment for it.10 To that end, several studies have vouched for CJC-1295 and ipamorelin, at least as separate therapies
Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort
Calcitriol has been shown to enhance autophagic activity in podocytes and tubular cells by restoring LC3-II expression and autophagic flux, while concurrently reducing apoptosis through the modulation of Bcl-2 and Bax expression (21)
